Literature DB >> 7620709

Participation of NMDA and non-NMDA excitatory amino acid receptors in the mediation of spinal reflex potentials in rats: an in vivo study.

S Farkas1, H Ono.   

Abstract

1. The effect of various intravenously administered excitatory amino acid (EAA) antagonists on the dorsal root stimulation-evoked, short latency (up to 10 ms) spinal root reflex potentials of chloralose-urethane anaesthetized C1 spinal rats was studied, in order to gain information on the involvement of non-NMDA (AMPA/kainate; AMPA = alpha-amino-3-hydroxy-5-methyl-isoxazole-4-propionate) and NMDA (N-methyl-D-aspartate) receptors in their mediation. The competitive non-NMDA antagonist, 2,3-dihydroxy-6-nitro-7-sulphamoyl-benzo(F)quinoxaline (NBQX; 1-32 mg kg-1), the non-competitive non-NMDA antagonist, 1-(amino)phenyl-4-methyl-7,8-methylendioxy-5H-2,3-benzodiazepine (GYKI 52466; 0.5-8 mg kg-1), the competitive NMDA antagonist 3-((+/-)-2-carboxypiperazin-4-yl)-propyl-l-phosphonic acid (CPP, 2-8 mg kg-1) and two non-competitive NMDA antagonists: MK-801 (0.5-2 mg kg-1) and ketamine (2-32 mg kg-1) were used as pharmacological tools. 2. Validating the applied pharmacological tools regarding selectivity at the applied doses, their effects were tested on direct (electrical) as well as on synaptic excitability of motoneurones evoked by intraspinal stimulation. Furthermore, their effect was investigated on the responses elicited by microiontophoretic application of EAA agonists (AMPA, kainate and NMDA) into the motoneurone pool, where the extracellular field potential evoked by antidromic stimulation of the ventral root was recorded to detect the effects of EAA agonists. 3. NBQX and GYKI 52466 were able to abolish completely the mono-, di- and polysynaptic ventral root reflexes (MSR, DSR, PSR) and the synaptic excitability of motoneurones, while hardly influencing direct excitability of motoneurones. They markedly attenuated AMPA and kainate responses whilst having little or no effect on NMDA responses. 4. Apparently 'supramaximal' doses of CPP and MK-801 slightly inhibited MSR (by about 10%) moderately reduced DSR and PSR (by about 20-30%) and did not influence excitability of motoneurones. They selectively blocked responses to NMDA. 5. Ketamine dose-dependently inhibited MSR, DSR and PSR. Nevertheless, diminution of none of the responses exceeded 50%. It reduced both direct and synaptic excitability of motoneurones, thus displaying a local anaesthetic-like effect, which may contribute to its reflex inhibitory action. It depressed responses to NMDA whilst having negligible effects on responses to AMPA and kainate. 6. We conclude that non-NMDA receptors play a substantial role in the mediation of MSR, DSR and PSR, while NMDA receptors contribute little to this. Neither MSR nor PSR is mediated exclusively by non-NMDA or NMDA receptors, respectively. 7. The drugs investigated in this study, with the exception of ketamine, proved to be useful tools for elucidation of the involvement of EAA receptors in various processes in vivo Keywords: Glutamate receptors; AMPA; kainate; NMDA; NBQX; GYKI 52466; CPP; MK-801; spinal reflex; spinal cord

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7620709      PMCID: PMC1510345          DOI: 10.1111/j.1476-5381.1995.tb13333.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  40 in total

1.  GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses.

Authors:  S D Donevan; M A Rogawski
Journal:  Neuron       Date:  1993-01       Impact factor: 17.173

2.  Responses of motoneurones to electrophoretically applied dopamine.

Authors:  S Barasi; M T Roberts
Journal:  Br J Pharmacol       Date:  1977-05       Impact factor: 8.739

3.  The modification of lumbar motoneurone excitability by stimulation of a putative 5-hydroxytryptamine pathway.

Authors:  S Barasi; M H Roberts
Journal:  Br J Pharmacol       Date:  1974-11       Impact factor: 8.739

4.  Mechanisms of depressant action of baclofen on the spinal reflex in the rat.

Authors:  H Ono; H Fukuda; Y Kudo
Journal:  Neuropharmacology       Date:  1979 Aug-Sep       Impact factor: 5.250

5.  An analysis of synaptic transmission to motoneurones in the cat spinal cord using a new selective receptor blocker.

Authors:  I Engberg; I Tarnawa; J Durand; M Ouardouz
Journal:  Acta Physiol Scand       Date:  1993-06

6.  A comparison of extracellular and intracellular recording during extracellular microiontophoresis.

Authors:  I Engberg; J A Flatman; J D Lambert
Journal:  J Neurosci Methods       Date:  1979-10       Impact factor: 2.390

7.  Role of excitatory amino acid receptors in mono- and polysynaptic excitation in the cat spinal cord.

Authors:  J Davies; J C Watkins
Journal:  Exp Brain Res       Date:  1983       Impact factor: 1.972

8.  Effects of beta-(p-chlorophenyl)-GABA (baclofen) on spinal synaptic activity.

Authors:  H Fukuda; Y Kudo; H Ono
Journal:  Eur J Pharmacol       Date:  1977-07-01       Impact factor: 4.432

9.  Effects of intravenous kainic acid, N-methyl-D-aspartate, and (--)-nuciferine on the cat spinal cord.

Authors:  P Polc; W Haefely
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-11       Impact factor: 3.000

10.  The action of N-methyl-D-aspartic and kainic acids on motoneurones with emphasis on conductance changes [proceedings].

Authors:  I Engberg; J A Flatman; J D Lambert
Journal:  Br J Pharmacol       Date:  1978-11       Impact factor: 8.739

View more
  6 in total

Review 1.  Silperisone: a centrally acting muscle relaxant.

Authors:  Sándor Farkas
Journal:  CNS Drug Rev       Date:  2006 Fall-Winter

2.  Increased incidence of gap junctional coupling between spinal motoneurones following transient blockade of NMDA receptors in neonatal rats.

Authors:  George Z Mentis; Eugenia Díaz; Linda B Moran; Roberto Navarrete
Journal:  J Physiol       Date:  2002-11-01       Impact factor: 5.182

Review 3.  Synaptic control of motoneuronal excitability.

Authors:  J C Rekling; G D Funk; D A Bayliss; X W Dong; J L Feldman
Journal:  Physiol Rev       Date:  2000-04       Impact factor: 37.312

4.  Spasticity therapy reacts to astrocyte GluA1 receptor upregulation following spinal cord injury.

Authors:  Julio Gómez-Soriano; Eider Goiriena; Julian Taylor
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

5.  NMDA receptor blockade maintains correlated motor neuron firing and delays synapse competition at developing neuromuscular junctions.

Authors:  Kirkwood E Personius; James L Karnes; Sara D Parker
Journal:  J Neurosci       Date:  2008-09-03       Impact factor: 6.167

Review 6.  Activity-dependent plasticity of spinal circuits in the developing and mature spinal cord.

Authors:  Behdad Tahayori; David M Koceja
Journal:  Neural Plast       Date:  2012-08-01       Impact factor: 3.599

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.